Long answer question (15marks) 1. Write a detail note on urea cycle with reaction? Mention its major metablic disorders . 2. Explain the transamination reaction ? Involved in the catabolism of amino acids. 3. What are the bile pigments. Name the diseases aassociated with their metablism. 4. What are transaminase. Write the fiagnostic importance of transaminases. 5. What are porphyrin. Explain the type and clinical importance of porphyria. Short answer question ( 5 marks) 1. Explain the transamination reaction involved in thr catabolism of amino avids. 2. Explain phenoketoneumia and alkaptoneumia 3. What is porphyria? 4. What is jaundice? Explain the different types of jaundice? 5. What is normal blood urea level? Name two condition in which blood urea level is elevated . Answer these for pharm d 1st year student with flowcharts, tables in understandable language and getting high score , effective content

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File

πŸ“š Pharm D 1st Year β€” Biochemistry Complete Notes


═══════════════════════════════════════

LONG ANSWER QUESTIONS (15 Marks Each)

═══════════════════════════════════════


LONG ANSWER 1 β€” Urea Cycle: Detailed Note with Reactions & Metabolic Disorders

πŸ”‘ Introduction

Urea (Hβ‚‚N–CO–NHβ‚‚) is the major disposal form of amino groups derived from amino acid catabolism. It accounts for ~90% of nitrogen-containing components of urine. Urea synthesis occurs exclusively in hepatocytes (liver cells). The cycle was first described in 1932 by Hans Krebs and Kurt Henseleit (originally called the Krebs–Henseleit cycle).
Key fact: Normal blood urea nitrogen (BUN) = 7–20 mg/dL; plasma ammonia (NH₄⁺) = 30–60 Β΅mol/L

πŸ”¬ Source of Nitrogen for Urea

Nitrogen AtomSource
1st NitrogenFree NH₃ (from glutamate via GDH β€” oxidative deamination)
2nd NitrogenAspartate (via transamination)
Carbon & OxygenCOβ‚‚ (as HCO₃⁻)

βš™οΈ Reactions of the Urea Cycle

The urea cycle has 5 major reactions. Steps 1–2 occur in the mitochondrial matrix; Steps 3–5 occur in the cytosol.

FLOWCHART β€” Urea Cycle

MITOCHONDRIA
───────────────────────────────────────────────────────
NH₄⁺ + HCO₃⁻ + 2ATP
        ↓ [CPS-I β€” activated by N-acetylglutamate (NAG)]
 β‘  CARBAMOYL PHOSPHATE (high-energy compound)
        ↓ + Ornithine
        ↓ [Ornithine Transcarbamylase (OTC)]
 β‘‘ CITRULLINE + Pα΅’
        ↓ (transported to cytosol via antiporter)
───────────────────────────────────────────────────────
CYTOSOL
───────────────────────────────────────────────────────
 Citrulline + Aspartate + ATP
        ↓ [Argininosuccinate Synthetase] β†’ AMP + PPα΅’
 β‘’ ARGININOSUCCINATE
        ↓ [Argininosuccinate Lyase]
 β‘£ ARGININE + Fumarate
        ↓ [Arginase-I (liver only)] + Hβ‚‚O
 β‘€ UREA + ORNITHINE ←────────────────────────────────┐
                                                      β”‚
         Ornithine transported back to mitochondria β”€β”€β”˜
Urea cycle diagram

πŸ“‹ Step-by-Step Reactions (Tabular)

StepReactionEnzymeLocationEnergy
1NH₄⁺ + HCO₃⁻ + 2ATP β†’ Carbamoyl phosphateCPS-I (activated by NAG)Mitochondria2 ATP consumed
2Carbamoyl-P + Ornithine β†’ Citrulline + Pα΅’OTC (Ornithine Transcarbamylase)Mitochondriaβ€”
3Citrulline + Aspartate + ATP β†’ ArgininosuccinateArgininosuccinate SynthetaseCytosol1 ATP β†’ AMP + PPα΅’
4Argininosuccinate β†’ Arginine + FumarateArgininosuccinate LyaseCytosolβ€”
5Arginine + Hβ‚‚O β†’ Urea + OrnithineArginase-ICytosol (liver)β€”

Overall Stoichiometry:

NH₄⁺ + HCO₃⁻ + Aspartate + 3 ATP + Hβ‚‚O
        β†’ Urea + Fumarate + 2 ADP + AMP + 2 Pα΅’ + PPα΅’
4 high-energy phosphate bonds are consumed per mole of urea. The cycle is irreversible (large negative Ξ”G).

πŸ§ͺ Regulation of the Urea Cycle

RegulatorEffectMechanism
N-Acetylglutamate (NAG)Activates CPS-I (rate-limiting enzyme)Allosteric activator β€” increases affinity of CPS-I for ATP
ArginineActivates NAGSStimulates NAG synthesis β†’ more CPS-I activation
Substrate availabilityShort-term regulationMore amino acid intake β†’ more NH₃ β†’ more urea
Enzyme inductionLong-term regulationHigh-protein diet upregulates urea cycle enzymes

⚠️ Major Metabolic Disorders of the Urea Cycle

When any enzyme of the urea cycle is deficient β†’ Hyperammonemia (ammonia accumulates) β†’ Toxic to CNS.

FLOWCHART β€” Urea Cycle Disorders

Step 1 β†’ CPS-I deficiency     β†’ ↑ NH₄⁺ (no carbamoyl phosphate formed)
Step 2 β†’ OTC deficiency        β†’ ↑ NH₄⁺ + ↑ Orotic acid in urine (most common; X-linked)
Step 3 β†’ AS deficiency         β†’ Citrullinemia (↑ citrulline in blood/urine)
Step 4 β†’ AL deficiency         β†’ Argininosuccinic acidemia (↑ argininosuccinate)
Step 5 β†’ Arginase deficiency   β†’ Argininemia (↑ arginine in blood)
DisorderDeficient EnzymeKey FeatureInheritance
CPS-I deficiencyCarbamoyl Phosphate Synthetase-ISevere hyperammonemia; no orotic acidAR
OTC deficiencyOrnithine TranscarbamylaseMost common; ↑ orotic acid in urineX-linked recessive
CitrullinemiaArgininosuccinate Synthetase↑ Citrulline in blood & urineAR
Argininosuccinic aciduriaArgininosuccinate Lyase↑ Argininosuccinate; brittle hair (trichorrhexis nodosa)AR
HyperargininemiaArginase-I↑ Arginine; spastic diplegia, seizuresAR
AR = Autosomal Recessive

Common Clinical Features of ALL Urea Cycle Disorders:

  • Neonatal vomiting, lethargy
  • Hyperammonemia β†’ Cerebral edema β†’ Coma β†’ Death
  • Protein aversion (older children)
  • Treatment: Low-protein diet + Sodium benzoate/phenylbutyrate (alternative nitrogen excretion pathways)

Other causes of Hyperammonemia:

  • Acquired (Liver disease): Viral hepatitis, alcoholic cirrhosis β†’ shunting of portal blood β†’ urea cycle bypassed
  • Liver failure β†’ ammonia cannot be converted to urea β†’ encephalopathy

LONG ANSWER 2 β€” Transamination Reaction in Catabolism of Amino Acids

πŸ”‘ Introduction

Transamination is the most important initial step in the catabolism of most amino acids. In this reaction, the Ξ±-amino group of an amino acid is transferred to an Ξ±-keto acid, producing a new amino acid and a new keto acid.

βš™οΈ General Reaction

       Amino Acid₁      +    Ξ±-Keto acidβ‚‚
            ↕ [Transaminase / Aminotransferase + PLP]
       Ξ±-Keto acid₁     +    Amino Acidβ‚‚
The most common pair:
Amino acid + Ξ±-Ketoglutarate  β‡Œ  Ξ±-Keto acid + Glutamate
                [Transaminase + PLP]
Example β€” Aspartate Transaminase (AST):
Aspartate + Ξ±-Ketoglutarate  β‡Œ  Oxaloacetate + Glutamate
Example β€” Alanine Transaminase (ALT):
Alanine + Ξ±-Ketoglutarate  β‡Œ  Pyruvate + Glutamate
Transamination reaction diagram

πŸ”¬ Key Features

FeatureDetail
EnzymesTransaminases / Aminotransferases
Coenzyme requiredPyridoxal Phosphate (PLP) β€” derived from Vitamin B₆
ReversibilityReactions are readily reversible
ExceptionsLysine and Threonine do NOT undergo transamination
Central acceptorΞ±-Ketoglutarate is almost always one of the pairs (produces glutamate)

πŸ”„ Mechanism (Step-by-Step)

Phase 1 β€” Amino group transfer TO enzyme (PLP β†’ PMP):
    Amino Acid + Enzyme-PLP β†’ Ξ±-Keto Acid + Enzyme-PMP

Phase 2 β€” Amino group transfer FROM enzyme (PMP β†’ PLP):
    Enzyme-PMP + Ξ±-Ketoglutarate β†’ Glutamate + Enzyme-PLP
PLP = Pyridoxal Phosphate (Schiff base with enzyme lysine) PMP = Pyridoxamine Phosphate

πŸ”— Role of Transamination in Amino Acid Catabolism (FLOWCHART)

Dietary Amino Acids (20 types)
        ↓ Transamination (collects Ξ±-amino groups)
        ↓ All nitrogen funneled β†’ GLUTAMATE
        ↓
   Glutamate Dehydrogenase (GDH)
        ↓ Oxidative Deamination
   Ξ±-Ketoglutarate + NH₄⁺
        ↓
   NH₄⁺ enters β†’ UREA CYCLE β†’ Urea (excreted)
   Ξ±-Keto acids β†’ TCA cycle / gluconeogenesis / ketogenesis

πŸ”— Link with Other Pathways

Ξ±-Keto Acid ProducedMetabolic Fate
Pyruvate (from Alanine)Gluconeogenesis, TCA cycle
Oxaloacetate (from Aspartate)TCA cycle, gluconeogenesis
Ξ±-Ketoglutarate (from Glutamate)TCA cycle
Acetoacetate (from Leucine/Lys)Ketogenesis

πŸ₯ Clinical Importance of Transamination

  • Basis of diagnostic importance of transaminases (see Long Answer 4)
  • Reversible reactions allow biosynthesis of non-essential amino acids
  • Central to the glucose–alanine cycle (muscle β†’ liver nitrogen transport)

LONG ANSWER 3 β€” Bile Pigments: Types, Metabolism & Associated Diseases

πŸ”‘ What Are Bile Pigments?

Bile pigments are colored degradation products of heme (the iron-containing prosthetic group of hemoglobin). They are excreted in bile. The principal bile pigments are:
  1. Bilirubin (yellow-orange) β€” major bile pigment
  2. Biliverdin (green) β€” intermediate
  3. Urobilinogen (colorless) β€” intestinal reduction product
  4. Urobilin / Stercobilin (yellow/brown) β€” oxidized urobilinogen

βš™οΈ Metabolism of Bilirubin (Step-by-Step Flowchart)

β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚  RBC breakdown (in spleen/liver/bone marrow)            β”‚
β”‚  Hemoglobin β†’ Heme + Globin                             β”‚
β”‚  Heme + Oβ‚‚ β†’ [Heme Oxygenase] β†’ Biliverdin + CO + Fe²⁺ β”‚
β”‚  Biliverdin β†’ [Biliverdin Reductase] β†’ BILIRUBIN        β”‚
β”‚            (Unconjugated / Indirect / Free)              β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
                   β”‚ Transported bound to ALBUMIN in blood
                   β–Ό
β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚  LIVER (Hepatocytes)                                    β”‚
β”‚  Bilirubin β†’ [UDP-Glucuronyl Transferase]               β”‚
β”‚           β†’ Bilirubin Diglucuronide                     β”‚
β”‚            (Conjugated / Direct / Water-soluble)         β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
                   β”‚ Excreted into bile β†’ intestine
                   β–Ό
β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚  INTESTINE                                              β”‚
β”‚  Bilirubin glucuronide β†’ [Intestinal bacteria]          β”‚
β”‚           β†’ Urobilinogen (colorless)                    β”‚
β”‚                β”œβ”€ 20% reabsorbed β†’ portal blood β†’ liver β”‚
β”‚                β”‚   (small amount β†’ kidney β†’ URINE       β”‚
β”‚                β”‚    as Urobilin = yellow color of urine) β”‚
β”‚                └─ 80% oxidized β†’ Stercobilin            β”‚
β”‚                   (brown color of feces)                 β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

πŸ“‹ Types of Bilirubin

PropertyUnconjugated (Indirect)Conjugated (Direct)
SolubilityWater-INSOLUBLEWater-SOLUBLE
TransportBound to albuminFree in plasma
Van den Bergh testIndirect reactionDirect reaction
Crosses BBBYes (toxic to brain)No
Present in urineNo (not filtered)Yes (bilirubinuria)
Normal plasma level~0.1–0.8 mg/dL<0.2 mg/dL
Total normal serum bilirubin: 0.3–1.0 mg/dL Jaundice appears when bilirubin >1.5–2 mg/dL (visually detectable ~3Γ— normal)

πŸ₯ Diseases Associated with Bile Pigment Metabolism

DiseaseTypeDefectBilirubin Type ↑
Hemolytic JaundicePre-hepaticExcessive RBC destruction β†’ excess bilirubin formationUnconjugated ↑↑
Hepatocellular JaundiceHepaticLiver cell damage (hepatitis, cirrhosis) β†’ impaired uptake + conjugation + excretionBoth types ↑
Obstructive JaundicePost-hepaticBile duct obstruction (gallstone, cancer) β†’ conjugated bilirubin regurgitatedConjugated ↑↑
Neonatal JaundicePhysiologicalImmature UDP-glucuronyl transferaseUnconjugated ↑
Crigler-Najjar SyndromeHereditaryAbsent (Type I) or deficient (Type II) UDP-glucuronyl transferaseUnconjugated ↑↑↑
Gilbert SyndromeHereditaryReduced UDP-glucuronyl transferase (~30% activity)Mild unconjugated ↑
Dubin-Johnson SyndromeHereditaryDefect in MRP2 (cannot excrete conjugated bilirubin into bile)Conjugated ↑
Rotor SyndromeHereditaryDefect in hepatic uptake and storageConjugated ↑
KernicterusComplicationUnconjugated bilirubin crosses BBB β†’ brain damage in neonatesUnconjugated ↑↑↑

LONG ANSWER 4 β€” Transaminases: Definition & Diagnostic Importance

πŸ”‘ Definition

Transaminases (also called Aminotransferases) are enzymes that catalyze transamination reactions β€” the transfer of an amino group (–NHβ‚‚) from an amino acid to an Ξ±-keto acid. All require pyridoxal phosphate (PLP) as coenzyme.

πŸ”¬ Clinically Important Transaminases

EnzymeFull NameOld NamePrimary Location
ASTAspartate AminotransferaseSGOT (Serum Glutamate Oxaloacetate Transaminase)Liver, heart, muscle, RBCs
ALTAlanine AminotransferaseSGPT (Serum Glutamate Pyruvate Transaminase)Liver (most specific)
Reactions:
AST: Aspartate + Ξ±-Ketoglutarate  β‡Œ  Oxaloacetate + Glutamate
ALT: Alanine   + Ξ±-Ketoglutarate  β‡Œ  Pyruvate     + Glutamate
Normal Reference Values:
EnzymeNormal Range
ASTUp to ~40 IU/L
ALTUp to ~40 IU/L
Blood half-life: AST = 17 h; ALT = 47 h; Mitochondrial AST = 87 h

πŸ₯ Diagnostic Importance of Transaminases

FLOWCHART β€” Disease Diagnosis Using AST & ALT

                  Serum Transaminases Elevated
                         /              \
               ALT > AST              AST >> ALT (ratio >2:1)
                  |                          |
         Acute Liver Disease         Alcoholic Hepatitis
       (Viral Hepatitis, Drugs)    (DeRitis Ratio = AST/ALT β‰₯3:1)
ConditionASTALTAST/ALT RatioNotes
Viral Hepatitis (Acute)↑↑↑ (500–5000 IU/L)↑↑↑↑ (higher than AST)<1ALT more specific for liver
Alcoholic Hepatitis↑↑↑ (lower)β‰₯2–3:1 (DeRitis ratio)Mitochondrial AST released by alcohol
Myocardial Infarction (MI)↑↑Normal/mildly ↑>1AST from heart muscle (troponin now preferred)
Liver Cirrhosis↑↑VariableReduced synthesis of both
Obstructive JaundiceMildly ↑Mildly ↑~1ALP more prominently elevated
Drug-induced hepatotoxicity↑↑↑↑↑<1Paracetamol overdose
Muscle Disease (Myopathy)↑↑Normal>3AST from muscle cells

Key Points for Exam:

  1. ALT is LIVER-SPECIFIC β€” predominantly found in liver cytoplasm; most sensitive marker of hepatocellular damage
  2. AST is LESS SPECIFIC β€” found in liver, heart, skeletal muscle, kidneys, RBCs
  3. DeRitis Ratio (AST/ALT):
    • >2 β†’ Alcoholic liver disease
    • <1 β†’ Viral hepatitis / non-alcoholic fatty liver
  4. Vitamin B₆ deficiency can give falsely LOW transaminase levels (PLP is required for enzyme activity β€” especially important in alcoholics)
  5. Both enzymes are used to monitor liver function, assess severity of hepatitis, guide treatment decisions, and detect drug toxicity

LONG ANSWER 5 β€” Porphyrins: Types and Clinical Importance of Porphyria

πŸ”‘ What Are Porphyrins?

Porphyrins are cyclic compounds formed by four pyrrole rings linked by methene bridges (–CH=). They have a unique ability to bind metal ions:
  • Fe²⁺ β†’ Heme (in hemoglobin, myoglobin, cytochromes)
  • Mg²⁺ β†’ Chlorophyll (plants)
  • Co²⁺ β†’ Vitamin B₁₂
Porphyrins are the backbone of heme, which is critical for oxygen transport and electron transfer.

βš™οΈ Heme Synthesis (Simplified)

MITOCHONDRIA:
Succinyl CoA + Glycine β†’ [ALA Synthase + PLP] β†’ Ξ΄-ALA (aminolevulinic acid)

CYTOSOL:
2Γ— Ξ΄-ALA β†’ [ALA Dehydratase] β†’ Porphobilinogen (PBG) β€” 1 pyrrole ring
4Γ— PBG β†’ [Hydroxymethylbilane Synthase] β†’ Hydroxymethylbilane
                β†’ Uroporphyrinogen III β†’ Coproporphyrinogen III

MITOCHONDRIA:
Coproporphyrinogen III β†’ Protoporphyrin IX
Protoporphyrin IX + Fe²⁺ β†’ [Ferrochelatase] β†’ HEME

πŸ”¬ Types of Porphyria

Porphyrias are a group of diseases caused by enzyme defects in the heme biosynthetic pathway β†’ accumulation of porphyrins or their precursors (ALA, PBG).

Classification:

PORPHYRIAS
    β”‚
    β”œβ”€β”€ HEPATIC (liver is primary site of overproduction)
    β”‚       β”œβ”€β”€ Acute Intermittent Porphyria (AIP) ← most common acute
    β”‚       β”œβ”€β”€ Porphyria Cutanea Tarda (PCT) ← most common overall
    β”‚       β”œβ”€β”€ Hereditary Coproporphyria (HCP)
    β”‚       └── Variegate Porphyria (VP)
    β”‚
    └── ERYTHROPOIETIC (bone marrow/RBCs)
            β”œβ”€β”€ Congenital Erythropoietic Porphyria (CEP) ← GΓΌnther disease
            └── Erythropoietic Protoporphyria (EPP)

πŸ“‹ Major Types β€” Detailed Table

TypeDeficient EnzymePrecursor/Porphyrin AccumulatedKey Clinical FeaturesInheritance
AIP (Acute Intermittent Porphyria)Hydroxymethylbilane synthase (HMB synthase) / PBG deaminaseALA, PBG (urine turns red/dark on standing)Abdominal pain, neuropsychiatric symptoms, no photosensitivityAD
Porphyria Cutanea Tarda (PCT)Uroporphyrinogen decarboxylaseUroporphyrin I & IIIPhotosensitivity, skin blistering, fragile skin, dark urineAcquired (most common)
Congenital Erythropoietic Porphyria (CEP)Uroporphyrinogen III synthaseUroporphyrin ISevere photosensitivity, hemolytic anemia, pink urine, red-stained teeth (erythrodontia)AR
Erythropoietic Protoporphyria (EPP)FerrochelataseProtoporphyrin IXPhotosensitivity (burning, itching), liver damageAD
Hereditary Coproporphyria (HCP)Coproporphyrinogen oxidaseCoproporphyrin IIIAbdominal pain + photosensitivityAD
Variegate Porphyria (VP)Protoporphyrinogen oxidasePorphyrins + ALA/PBGAbdominal pain + photosensitivity; "South African type"AD
AD = Autosomal Dominant; AR = Autosomal Recessive

⚠️ Clinical Importance of Porphyria

Two Main Clinical Manifestations:

ACUTE ATTACKS (Neuropsychiatric)          CUTANEOUS (Photosensitivity)
β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”                    β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”
Caused by ALA + PBG accumulation          Caused by porphyrin accumulation
(toxic to nervous system)                 (porphyrins absorb light β†’ Oβ‚‚ radicals)

Symptoms:                                  Symptoms:
β€’ Severe colicky abdominal pain            β€’ Blistering, erosions on sun-exposed skin
β€’ Nausea, vomiting                         β€’ Hyperpigmentation
β€’ Motor neuropathy (weakness/paralysis)    β€’ Fragile skin
β€’ Neuropsychiatric symptoms               β€’ Hypertrichosis
β€’ Tachycardia, hypertension               β€’ Red/pink urine or teeth

Precipitating Factors for Acute Attacks:

  • Drugs (barbiturates, sulfonamides, alcohol, estrogens) β€” induce ALA synthase
  • Fasting/starvation
  • Hormonal changes (menstruation, pregnancy)
  • Infections

Diagnosis:

  • ↑ Urinary ALA and PBG (Watson-Schwartz test β€” positive in AIP)
  • Urine turns port-wine red on standing (oxidation of PBG)
  • Stool porphyrins
  • Fluorescence of porphyrins under UV light (Wood's lamp)

Treatment:

  • Acute attack: IV Glucose (suppresses ALA synthase) + IV Hemin (negative feedback on ALA synthase)
  • Avoid precipitating drugs
  • Sunscreen and sun protection (for cutaneous types)


═══════════════════════════════════

SHORT ANSWER QUESTIONS (5 Marks)

═══════════════════════════════════


SHORT ANSWER 1 β€” Transamination Reaction in Catabolism of Amino Acids

Transamination = Transfer of the Ξ±-amino group from an amino acid to an Ξ±-keto acid.
Amino Acid + Ξ±-Ketoglutarate  β‡Œ  Ξ±-Keto Acid + Glutamate
              [Transaminase / PLP]
Key Points:
  • Enzyme: Aminotransferase (Transaminase)
  • Coenzyme: PLP (Pyridoxal Phosphate = Vitamin B₆ derivative)
  • All amino acids except Lysine and Threonine undergo transamination
  • Reactions are reversible β€” used in both catabolism and synthesis
  • Most reactions use Ξ±-ketoglutarate as the amino group acceptor β†’ forming glutamate, which then undergoes oxidative deamination (by GDH) to release NH₄⁺ β†’ enters urea cycle
  • Most important transaminases clinically: ALT (liver marker) and AST (liver + heart marker)

SHORT ANSWER 2 β€” Phenylketonuria (PKU) and Alkaptonuria

A. Phenylketonuria (PKU)

FeatureDetail
Enzyme DeficiencyPhenylalanine Hydroxylase (PAH) β€” converts Phe β†’ Tyr
CausePAH deficiency OR tetrahydrobiopterin (BHβ‚„) deficiency
InheritanceAutosomal Recessive
Accumulated MetabolitePhenylalanine β†’ Phenylpyruvate (β†’ phenyllactate, phenylacetate)
Flowchart:
Phenylalanine  β†’[PAH - BLOCKED]β†’  Tyrosine (CANNOT form normally)
      ↓
Phenylpyruvate (transamination)
      ↓
Phenyllactate / Phenylacetate
      ↓
Excreted in urine β†’ "mousy/musty" odor
Clinical Features:
  • Intellectual disability (untreated) β€” phenylpyruvate is toxic to brain
  • Fair skin, hair, eyes (reduced melanin β€” needs Tyr)
  • Eczema
  • Seizures
  • Musty odor of urine and sweat (phenylacetate)
Screening: Guthrie test (heel-prick in neonates) Treatment: Low phenylalanine diet (from birth); Sapropterin (BHβ‚„) for responsive cases

B. Alkaptonuria

FeatureDetail
Enzyme DeficiencyHomogentisate Oxidase (homogentisate 1,2-dioxygenase)
PathwayTyrosine catabolism β†’ Homogentisate CANNOT be oxidized further
InheritanceAutosomal Recessive
Flowchart:
Tyrosine β†’ Homogentisate β†’[Homogentisate Oxidase β€” BLOCKED]β†’ Maleylacetoacetate
                ↓
         Accumulates β†’ auto-oxidizes β†’ dark pigment (ALKAPTON)
                ↓
         β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
         β”‚ Urine turns dark (black/brown)β”‚ β†’ "Black urine disease"
         β”‚ on exposure to air            β”‚
         β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
         Deposited in cartilage β†’ OCHRONOSIS (bluish-black pigmentation)
         β†’ Arthritic joint pain (later in life)
Clinical Features:
  • Dark/black urine (classic sign)
  • Ochronosis (pigmentation of cartilage, tendons, connective tissue)
  • Arthritis (especially spine, large joints)
  • Stains diapers of affected infants
Treatment: Low phenylalanine + low tyrosine diet; Nitisinone (NTBC) drug

SHORT ANSWER 3 β€” What is Porphyria?

Porphyria is a group of inherited (or acquired) metabolic disorders caused by enzyme deficiencies in the heme biosynthetic pathway, leading to accumulation of porphyrins or their precursors (ALA and PBG).
Normal: Glycine + Succinyl CoA β†’ ALA β†’ PBG β†’ Porphyrins β†’ Heme
                                                   ↑
                        ENZYME BLOCK HERE causes accumulation
Two Main Types:
  1. Acute (Hepatic) Porphyrias β†’ Accumulate ALA & PBG β†’ Neuropsychiatric + abdominal pain
    • Most important: Acute Intermittent Porphyria (AIP)
  2. Cutaneous Porphyrias β†’ Accumulate porphyrins β†’ Photosensitivity + skin lesions
    • Most common: Porphyria Cutanea Tarda (PCT)
Classic triad of AIP:
  • Abdominal pain (severe, colicky)
  • Neuropsychiatric symptoms (anxiety, psychosis)
  • Dark red/port-wine urine (on standing)
Key fact: Barbiturates and sulfonamides can precipitate acute attacks β†’ contraindicated in porphyria patients

SHORT ANSWER 4 β€” Jaundice: Definition and Types

Definition

Jaundice (Icterus) is a yellowish discoloration of skin, mucous membranes, and sclera due to elevated serum bilirubin levels (>1.5–2 mg/dL). It is clinically detectable when total bilirubin exceeds ~3Γ— normal (~1.5 mg/dL).

Types of Jaundice

                        JAUNDICE
                           β”‚
          β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
          β–Ό                β–Ό                β–Ό
   PRE-HEPATIC        HEPATIC           POST-HEPATIC
 (Hemolytic)       (Hepatocellular)    (Obstructive)
FeaturePre-hepatic (Hemolytic)Hepatic (Hepatocellular)Post-hepatic (Obstructive)
CauseExcessive RBC hemolysisLiver cell damageBile duct obstruction
ExamplesMalaria, sickle cell, thalassemiaViral hepatitis, cirrhosisGallstones, pancreatic cancer
Bilirubin type ↑Unconjugated ↑↑Both types ↑Conjugated ↑↑
Urine bilirubinAbsent (Acholuric jaundice)PresentPresent (dark urine)
Urine urobilinogen↑↑ (increased)↑Absent (total obstruction)
Stool colorDark (↑ stercobilin)Pale/normalPale/clay-colored
PruritusAbsentVariablePresent (bile salts in skin)
ALT/ASTNormal↑↑↑Mildly ↑
ALPNormalMildly ↑↑↑↑
Van den BerghIndirect positiveBothDirect positive

Neonatal Jaundice (Physiological Jaundice):

  • Appears at day 2–3; resolves by day 10
  • Cause: Immature UDP-glucuronyl transferase + rapid hemolysis of fetal RBCs
  • Unconjugated bilirubin ↑ β†’ can cross BBB β†’ Kernicterus (brain damage) if severe

SHORT ANSWER 5 β€” Normal Blood Urea Level & Conditions of Elevated Blood Urea

Normal Blood Urea Level:

ParameterNormal Value
Blood Urea Nitrogen (BUN)7–20 mg/dL
Serum Urea15–45 mg/dL (varies by lab)
Plasma Ammonia30–60 Β΅mol/L
Note: BUN Γ— 2.14 = Serum Urea (approximately)

Elevated Blood Urea = UREMIA / AZOTEMIA

Two Important Conditions Where Blood Urea is Elevated:

1. Renal Failure (Kidney Disease)

Damaged kidneys β†’ ↓ GFR β†’ Cannot filter/excrete urea β†’ Urea accumulates in blood
β†’ UREMIA (symptoms: nausea, vomiting, fatigue, confusion, "uremic frost")
  • Pre-renal azotemia: Dehydration, heart failure β†’ ↓ blood flow to kidneys
  • Renal azotemia: Glomerulonephritis, pyelonephritis, diabetic nephropathy
  • Post-renal azotemia: Obstruction (stones, prostate enlargement)

2. High Protein Intake / Increased Protein Catabolism

↑ Protein intake β†’ ↑ Amino acid catabolism β†’ ↑ NH₄⁺ β†’ ↑ Urea synthesis β†’ ↑ Blood urea
Also: Fever, burns, starvation, trauma β†’ ↑ tissue protein breakdown β†’ ↑ urea

Summary Table:

ConditionMechanismBUN
Chronic Kidney Disease↓ GFR β†’ ↓ urea excretion↑↑↑
Acute Renal FailureSudden ↓ kidney function↑↑
High-protein diet↑ amino acid catabolism β†’ ↑ urea synthesisMildly ↑
Dehydration↓ renal perfusion + hemoconcentration↑
GI hemorrhageBlood protein digested in gut β†’ NH₄⁺ absorbed↑
Severe burns/trauma↑ protein catabolism↑
Liver failure↓ urea synthesis β†’ ↑ NH₄⁺ (opposite β€” urea may be LOW)↓ or Normal

πŸ“ Quick Revision Summary Table

TopicKey EnzymeKey MetaboliteDisease
Urea CycleCPS-I (rate-limiting)UreaHyperammonemia, OTC deficiency
TransaminationALT, AST (PLP needed)GlutamateHepatitis, MI, alcoholic liver disease
Bile PigmentsUDP-Glucuronyl TransferaseBilirubinJaundice, Crigler-Najjar, Gilbert, Dubin-Johnson
PorphyriaALA Synthase (rate-limiting)ALA, PBG, PorphyrinsAIP, PCT, CEP
PKUPhenylalanine HydroxylasePhenylpyruvateIntellectual disability, fair skin
AlkaptonuriaHomogentisate OxidaseHomogentisateBlack urine, Ochronosis

Sources: Lippincott Illustrated Reviews: Biochemistry, 8th ed.; Basic Medical Biochemistry: A Clinical Approach, 6th ed.; Harper's Illustrated Biochemistry, 32nd ed.; Guyton & Hall Textbook of Medical Physiology; Henry's Clinical Diagnosis and Management by Laboratory Methods
This is a shared conversation. Sign in to Orris to start your own chat.